Analyst Ratings for [AMRS] Amyris, Inc.

5/18/23	Downgrades	Buy Hold	X
AMRS Amyris Jefferies
$3.10 $0.65
5/10/23	Downgrades	Outperform Mkt Perform	X
AMRS Amyris TD Cowen
$4 $1.25
4/28/23	Initiated	Buy	X
AMRS Amyris Canaccord Genuity
$1.50
11/10/22	Downgrades	Overweight Neutral	X
AMRS Amyris JP Morgan
11/9/22	Downgrades	Outperform Perform	X
AMRS Amyris Oppenheimer
8/10/22	Downgrades	Buy Neutral	X
AMRS Amyris ROTH Capital
$4 $2
6/24/22	Initiated	Neutral	X
AMRS Amyris JP Morgan
5/25/22	Initiated	Neutral	X
AMRS Amyris Piper Sandler
$2.50
10/15/21	Resumed	Outperform	X
AMRS Amyris Cowen
$19
6/1/21	Initiated	Buy	X
AMRS Amyris HSBC Securities
$20
3/3/21	Reiterated	Buy	X
AMRS Amyris H.C. Wainwright
$11 $35
2/26/21	Initiated	Buy	X
AMRS Amyris ROTH Capital
$20
1/6/21	Upgrades	Mkt Perform Outperform	X
AMRS Amyris Cowen
$9
11/14/18	Reiterated	Buy	X
AMRS Amyris B. Riley FBR
$10 $8

AMRS Amyris, Inc.

Quotes: Barrons • SeekingAlpha • NASDAQ • Bloomberg • WSJ

Amyris, Inc. is an integrated industrial biotechnology company. The Company is engaged in research and development and sales of fuels and farnesene-derived products. It is applying its industrial synthetic biology platform to engineer, manufacture and sell products into a range of consumer and industrial markets, including cosmetics, flavors and fragrances (F&F), solvents and cleaners, polymers, lubricants, healthcare products and fuels. The Company focuses on a renewable hydrocarbon molecule called farnesene (Biofene). The Company is expanding its range of products across various categories divided into consumer and industrial applications. For consumer applications, the Company is developing and selling personal care products (which include ingredients for cosmetics and F&F), healthcare products and formulated end user products, such as Biossance brand skincare products and Muck Daddy brand hand cleaner product.